Webinar: CDC and WHO Review Current PrEP Guidelines - April 4, 2017

April 4, 2017
10am US ET / 4pm CET
via AVAC

Last month hundreds of people tuned in to hear researchers discuss the available data on "time to protection" required for effective oral PrEP with TDF/FTC—i.e., how many doses must be taken to build up protective levels of the drug in the blood? The answer is—it varies. Not surprisingly then, so do the guidelines for PrEP use.

As webinar participants learned, the data are varied and subject to interpretation. The World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) recommend different time frames to reach protection in their respective guidelines for oral PrEP use. Both of these recommendations are based on measurements of the amount of drug that accumulates in blood and/or tissue over a specific period of time. The studies of how drugs are taken into the body and how they leave the body is called "pharmacokinetics" and "pharmacodynamics" or "PK" and "PD" for short, as explained in our primer for advocates. There isn’t a single PK measurement that is associated with PrEP protection—so both WHO and CDC guidelines are based on inference.

Join us for a follow-on webinar presentation and Q&A scheduled for Tuesday, April 4, 10am US ET / 4pm CET when representatives from both CDC and WHO will review their respective guidance development processes and the role, use, contexts and audience for guidance documents.

Register here.

We hope this webinar will further the dialogue, and please join us.

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

There are several different options for reducing the chances of passing on HIV while trying to get pregnant. If you are a woman living with HIV and an HIV-negative man seeking information on getting pregnant, the options below will help you understand what might be the best for you, and prepare for discussions with your health care provider.

The number of older women living with HIV is growing. Read about aging with HIV, aging-related health challenges, stigma and support, and more.

The 2010 WRI meeting aimed to address the complex question: What makes women vulnerable to HIV infection, and once infected, to disease progression? 

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>